TNFRSF10C and cancer: There are some indications, however, that TRAIL receptors in cancer have an anti-apoptotic role via the NF-кB survival pathway and hence silencing of DCR1 would subject a cancer cell to a pro-survival and pro-growth signal [25, 26].